Ahmed F Mohamed
Overview
Explore the profile of Ahmed F Mohamed including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
188
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Al-Karmalawy A, Mohamed A, Shalaby H, Elmaaty A, El-Shiekh R, Zeidan M, et al.
RSC Med Chem
. 2025 Mar;
PMID: 40027342
Alzheimer's disease (AD) stands as one of the most outstanding progressive neurodegenerative disorders. Obviously, acetylcholine esterase (AChE) is the primary enzyme responsible for breaking down acetylcholine (ACh) with a much...
2.
Khidr E, Morad N, Hatem S, El-Dessouki A, Mohamed A, El-Shiekh R, et al.
Naunyn Schmiedebergs Arch Pharmacol
. 2025 Feb;
PMID: 39954069
Diabetic retinopathy (DR) represents a significant and serious complication associated with diabetes mellitus (DM), often resulting in considerable visual impairment or even blindness. The intricate pathological processes underlying DR complicate...
3.
Eladawy R, Ahmed L, Salem M, El-Sayed R, Salem H, Mohamed A
Int Immunopharmacol
. 2025 Feb;
150:114227.
PMID: 39952008
Recent studies propose an association between the prolonged usage of gastric acid suppressants (GAS) and the incidence of dementia in stressed patients. This association was confirmed in our investigation recently...
4.
Shokr M, Badawi G, Elshazly S, Zaki H, Mohamed A
ACS Pharmacol Transl Sci
. 2025 Jan;
8(1):47-65.
PMID: 39816800
Sigma 1 receptor (S1R) is a multifunctional, ligand-activated protein located in the membranes of the endoplasmic reticulum (ER). It mediates a variety of neurological disorders, including epilepsy, amyotrophic lateral sclerosis,...
5.
Basiouny S, Zaki H, Elshazly S, Mohamed A
Neuropharmacology
. 2025 Jan;
267:110295.
PMID: 39800083
Seizures can lead to cardiac dysfunction. Multiple pathways contribute to this phenomenon, of which the chaperone sigma-1 receptor (S1R) signaling represents a promising nexus between the abnormalities seen in both...
6.
Mohamed A, El-Gammal M, El-Yamany M, Khodeir A
Prog Neuropsychopharmacol Biol Psychiatry
. 2024 Nov;
136():111192.
PMID: 39510157
Autism spectrum disorder (ASD) is a neurodevelopmental disorder. While, fluvoxamine (FVX) is an antidepressant and widely prescribed to ASD patients, clinical results are inconclusive and the mechanism of FVX in...
7.
Abo-Elmagd I, Mahmoud A, Al-Ghobashy M, Nebsen M, Rabie M, Mohamed A, et al.
BMC Chem
. 2024 Nov;
18(1):214.
PMID: 39497217
The cardioprotective drug cyclocreatine phosphate has been awarded Food and Drug Administration-orphan drug designation for the prevention of ischemic injury to enhance cardiac graft recovery and survival in heart transplantation....
8.
Shafiek M, Zaki H, Mohamed A
Fundam Clin Pharmacol
. 2024 Nov;
39(1):e13041.
PMID: 39496328
Background: Fibromyalgia (FM) is a syndrome of pervasive chronic pain accompanied by low mood, sleep disorders, and cognitive decline. The dysfunction of central pain processing systems along with neurotransmitter disturbances...
9.
Khalil A, Sabry O, El-Askary H, El Zalabani S, Eltanany B, Pont L, et al.
BMC Complement Med Ther
. 2024 Nov;
24(1):379.
PMID: 39482666
Methods: In this study, the metabolite profiles of the 70% ethanolic extracts of PS wastes, namely peels (PSP) and a combination of leaves and stems (PSLS), were investigated by liquid...
10.
El-Sawaf E, El Maraghy N, El-Abhar H, Zaki H, Zordoky B, Ahmed K, et al.
Toxicol Appl Pharmacol
. 2024 Oct;
492:117134.
PMID: 39461624
Vincristine (VCR), an anti-tubulin chemotherapy agent, is known to cause peripheral and central nerve damage, inducing severe chemotherapy-induced peripheral neuropathy (CIPN). Although melatonin has been recently recognized for its potential...